Be part of the knowledge.™

Cardiology

2249

LikeLikedUnlike

166-180 of 883

CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Heart Matters
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
Heart Matters
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Dave L. Dixon, PharmD, FACC, FCCP, FNLA, BCPS, BCACP, CDE, CLS
  Peer
SELECT Trial: Semaglutide Lowers CVD Risk in Patients with Obesity
Heart Matters
SELECT Trial: Semaglutide Lowers CVD Risk in Patients with Obesity
Learning About the New Definition of MASLD
GI Insights
Learning About the New Definition of MASLD
- Peter Buch, MD, FACG, AGAF, FACP
  Peer
- Paul Kwo, MD
  Peer
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
Heart Matters
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Javed Butler, MD
  Peer
A Discussion on Statins to Lower CVD Risk for HIV Patients
Heart Matters
A Discussion on Statins to Lower CVD Risk for HIV Patients
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Steve Grinspoon, MD
  Peer
advertisement
Increasing BP Control with the AMA MAP™ Hypertension Program
Perspectives with the AMA
Increasing BP Control with the AMA MAP™ Hypertension Program
- Jennifer Caudle, DO, FACOFP
  Peer
- Chantal Tinfang, MD
  Peer
- Kesha Love, MSN, RN
  Peer
A Discussion on the Updated Recommendations for Managing Dyslipidemia in Adults
Heart Matters
A Discussion on the Updated Recommendations for Managing Dyslipidemia in Adults
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA
  Peer
Identifying Cardiovascular Risk Factors for HIV Patients
Heart Matters
Identifying Cardiovascular Risk Factors for HIV Patients
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Steve Grinspoon, MD
  Peer
Exploring Emerging Non-Statin LDL Lowering Therapies
Heart Matters
Exploring Emerging Non-Statin LDL Lowering Therapies
- Alan S. Brown, MD, FACC, FAHA, FNLA
  Peer
- Maya S. Safarova, MD, PhD, FNLA
  Peer
Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials
Heart Matters
Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Alan S. Brown, MD, FACC, FAHA, FNLA
  Peer
Genetic Guidance in Action: A Study for Selecting Oral P2Y Inhibitor
Heart Matters
Genetic Guidance in Action: A Study for Selecting Oral P2Y Inhibitor
advertisement
Stanford Surgeons Perform First Beating-Heart Procedure
Heart Matters
Stanford Surgeons Perform First Beating-Heart Procedure
- Javed Butler, MD
  Peer
- John W. MacArthur
  Peer
mAB Treatment for COVID-19 Does Not Impact HDP Rates
Advances in Women's Health
mAB Treatment for COVID-19 Does Not Impact HDP Rates
Investigating the Impact of Bempedoic Acid on Cardiovascular Outcomes in Statin-Intolerant Patients
Diabetes Discourse
Investigating the Impact of Bempedoic Acid on Cardiovascular Outcomes in Statin-Intolerant Patients
- John Buse, MD, PhD
  Peer
- Steven Nissen, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended